AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2014
Mar 24, 2014
34117_dirs_2014-03-24_af856c3d-8940-4fe4-a92b-c12d0d831657.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-03-21
Reporting Person: KUMAR AMIT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-21 | Common Stock | P | 5000 | $0.285 | Acquired | 513804 | Direct |
| 2014-03-21 | Common Stock | P | 10000 | $0.29 | Acquired | 523804 | Direct |
| 2014-03-24 | Common Stock | P | 30000 | $0.29 | Acquired | 553804 | Direct |
| 2014-03-24 | Common Stock | P | 10000 | $0.2875 | Acquired | 563804 | Direct |
| 2014-03-24 | Common Stock | P | 50000 | $0.285 | Acquired | 613804 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6